NatureWise Biotech & Medicals Corporation

NT$14.80As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4732Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (0.91%)
Div yield —
ROE (26.83%)
Biotechnology
Beta (5Y) 0.70
PE TTM —
TSR TTM (25.63%)
Mkt cap NT$717.2M
ROIC (70.96%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$19
25.10%
(12.54%)
Hold 12|9|11|7|0
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.35
0.39
0.42
0.43
20.16%
22.76%
21.22%
27.93%
RevenueNT$M
32.56
33.61
33.80
34.26
8.37%
10.99%
9.82%
8.18%
Peers (US$21.66M)
Cap (US$)
PE
21.97M
17.86x
Capital
TTM
5Y
10Y
Leveragex
0.537
0.810
0.615
EBIT/Intx
4.660
0.085
0.077
Own earn%
(18.13)
(163.29)
(149.68)
Sh yield%
38.24
41.30
42.29
Owners
Insiders/Inst%
0.77
82.89
Short interest%
5.42
SBC / revenue%
5.05
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
27–33
$1 testx
—
Incr. ROIC%
13